These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2967830)

  • 21. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iohexol versus iopamidol for cervical myelography: a randomised double blind study.
    Macpherson P; Teasdale E; Coutinho C; McGeorge A
    Br J Radiol; 1985 Sep; 58(693):849-51. PubMed ID: 3916061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelography with metrizamide--an analysis of the complications encountered in cervical, thoracic and lumbar myelography.
    McCormick CC; ApSimon HT; Chakera TM
    Aust N Z J Med; 1981 Dec; 11(6):645-50. PubMed ID: 6949540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelography with metrizamide in the cervical region.
    Ahlgren P
    Acta Radiol Suppl; 1977; 355():98-104. PubMed ID: 299690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intrathecal iohexol on visual evoked response latency: a comparison including incidence of headache with iopamidol and metrizamide in myeloradiculography.
    Broadbridge AT; Bayliss SG; Brayshaw CI
    Clin Radiol; 1987 Jan; 38(1):71-4. PubMed ID: 3545637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient lumbar myelography. Initial results in 79 examinations using a low-dose metrizamide technique.
    Tate CF; Wilkov HR; Lestrange NR; Gardiner HF; Stein KR
    Radiology; 1985 Nov; 157(2):391-3. PubMed ID: 4048446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
    Ndosi BN; Ndosi NK; Kazema RR
    Cent Afr J Med; 1996 Jul; 42(7):192-5. PubMed ID: 8936782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F-responses after metrizamide and iohexol lumbar myelography.
    Sand T
    Neuroradiology; 1988; 30(6):534-7. PubMed ID: 3226541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and affective changes after myelography: a comparison of metrizamide and iohexol.
    Ratcliff G; Sandler S; Latchaw R
    AJR Am J Roentgenol; 1986 Oct; 147(4):777-81. PubMed ID: 3489380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iohexol cervical myelography in adult outpatients.
    Wang H; Kumar AJ; Zinreich SJ; Higgins YM; Long DM; Bryan RN
    Spine (Phila Pa 1976); 1991 Dec; 16(12):1356-8. PubMed ID: 1771464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography].
    Lovrencić M; Klanfar Z; Jakovac I
    Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199
    [No Abstract]   [Full Text] [Related]  

  • 33. Cervical and lumbar routes for metrizamide cervical examination.
    Sackett JF
    Neuroradiology; 1978; 16():273-4. PubMed ID: 740192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ambulatory myelography using iohexol (Omnipaque): methods and results].
    Wilms G; Rigauts H; Baert AL; Plets C; Carton H; Goffin J; Van den Bergh R
    J Belge Radiol; 1989 Jun; 72(3):159-64. PubMed ID: 2529248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of iohexol and iopamidol for lumbar myelography.
    Hoe JW; Ng AM; Tan LK
    Clin Radiol; 1986 Sep; 37(5):505-7. PubMed ID: 3530602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system reactions to cervical myelography.
    Vestergaard A; Dons K; Eskesen V; Kruse-Larsen C; Lyon BB; Søborg PA; Jensen NO; Praestholm J
    Acta Radiol; 1991 Sep; 32(5):411-4. PubMed ID: 1910998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex and age related differences in postmyelographic adverse reactions. A prospective study of 1765 myelographies.
    Maly P
    Neuroradiology; 1989; 31(4):331-5. PubMed ID: 2797425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical myelography with metrizamide using lumbar injection.
    Sortland O
    Acta Radiol Suppl; 1977; 355():141-53. PubMed ID: 299663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iohexol lumbar myelography: clinical study.
    Holder JC; Binet EF; Kido DK; Belanger G; Sands MS
    AJNR Am J Neuroradiol; 1984; 5(4):399-402. PubMed ID: 6431775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.